Cargando…
Changes in body mass index and hemoglobin concentration in breastfeeding women living with HIV with a CD4 count over 350: Results from 4 African countries (The ANRS 12174 trial)
INTRODUCTION: Breastfeeding is recommended for infants born to HIV-infected women in low-income settings. Both breastfeeding and HIV-infection are energy demanding. Our objective was to explore how exclusive and predominant breastfeeding changes body mass index (BMI) among breastfeeding HIV1-positiv...
Autores principales: | Somé, Eric Nagaonlé, Engebretsen, Ingunn M. S., Nagot, Nicolas, Meda, Nicolas Y., Vallo, Roselyne, Kankasa, Chipepo, Tumwine, James K., Singata, Mandisa, Hofmeyr, Justus G., Van de Perre, Philippe, Tylleskär, Thorkild |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423645/ https://www.ncbi.nlm.nih.gov/pubmed/28486519 http://dx.doi.org/10.1371/journal.pone.0177259 |
Ejemplares similares
-
HIV-1 disease progression in immune-competent HIV-1-infected and breastfeeding mothers participating in the ANRS 12174 clinical trial in Burkina Faso, South Africa, Uganda and Zambia: a cohort study
por: Somé, Eric Nagaonle, et al.
Publicado: (2018) -
Breastfeeding patterns and its determinants among mothers living with Human Immuno-deficiency Virus -1 in four African countries participating in the ANRS 12174 trial
por: Somé, Eric N., et al.
Publicado: (2017) -
Lopinavir/Ritonavir versus Lamivudine peri-exposure prophylaxis to prevent HIV-1 transmission by breastfeeding: the PROMISE-PEP trial Protocol ANRS 12174
por: Nagot, Nicolas, et al.
Publicado: (2012) -
Mitochondrial DNA Parameters in Blood of Infants Receiving Lopinavir/Ritonavir or Lamivudine Prophylaxis to Prevent Breastfeeding Transmission of HIV-1
por: Monnin, Audrey, et al.
Publicado: (2020) -
Longitudinal Follow-Up of Blood Telomere Length in HIV-Exposed Uninfected Children Having Received One Year of Lopinavir/Ritonavir or Lamivudine as Prophylaxis
por: Monnin, Audrey, et al.
Publicado: (2021)